Publication: The neuroprotective effect of olanzapine
dc.contributor.author | Ozan, Erol | |
dc.contributor.buuauthor | Yuluğ, Burak | |
dc.contributor.buuauthor | Bakar, Mustafa | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | Nöroloji Ana Bilim Dalı | |
dc.contributor.orcid | 0000-0002-9704-6173 | |
dc.contributor.researcherid | O-8322-2016 | |
dc.contributor.researcherid | AAD-3930-2022 | |
dc.contributor.scopusid | 6507583384 | |
dc.contributor.scopusid | 26643051200 | |
dc.date.accessioned | 2024-03-28T12:55:52Z | |
dc.date.available | 2024-03-28T12:55:52Z | |
dc.date.issued | 2008 | |
dc.identifier.citation | Yuluğ, B. vd. (2008). "The neuroprotective effect of olanzapine". Journal of Neuropsychiatry and Clinical Neurosciences, 20(1), 107-108. | |
dc.identifier.endpage | 108 | |
dc.identifier.issn | 0895-0172 | |
dc.identifier.issue | 1 | |
dc.identifier.pubmed | 18305294 | |
dc.identifier.scopus | 2-s2.0-39749139311 | |
dc.identifier.startpage | 107 | |
dc.identifier.uri | https://doi.org/10.1176/appi.neuropsych.20.1.107-a | |
dc.identifier.uri | https://neuro.psychiatryonline.org/doi/full/10.1176/jnp.2008.20.1.107a | |
dc.identifier.uri | https://hdl.handle.net/11452/40659 | |
dc.identifier.volume | 20 | |
dc.identifier.wos | 000253311000016 | |
dc.indexed.wos | SCIE | |
dc.language.iso | en | |
dc.publisher | Amer Psychiatric Publishing | |
dc.relation.collaboration | Yurt içi | |
dc.relation.journal | Journal of Neuropsychiatry and Clinical Neurosciences | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Schizophrenia | |
dc.subject | Neuroleptics | |
dc.subject | Brain | |
dc.subject | Neurosciences & NeurologyPsychiatry Web of Science CategoriesClinical Neurolo | |
dc.subject | Psychiatry | |
dc.subject.emtree | Drug vehicle | |
dc.subject.emtree | Neuroleptic agent | |
dc.subject.emtree | Olanzapine | |
dc.subject.emtree | Animal cell | |
dc.subject.emtree | Animal experiment | |
dc.subject.emtree | Animal model | |
dc.subject.emtree | Animal tissue | |
dc.subject.emtree | Brain infarction | |
dc.subject.emtree | Controlled study | |
dc.subject.emtree | Disease course | |
dc.subject.emtree | Dose response | |
dc.subject.emtree | Drug efficacy | |
dc.subject.emtree | Letter | |
dc.subject.emtree | Long term care | |
dc.subject.emtree | Male | |
dc.subject.emtree | Middle cerebral artery occlusion | |
dc.subject.emtree | Mouse | |
dc.subject.emtree | Neuroimaging | |
dc.subject.emtree | Neuroprotection | |
dc.subject.emtree | Neurotoxicity | |
dc.subject.emtree | Nonhuman | |
dc.subject.emtree | Nuclear magnetic resonance imaging | |
dc.subject.emtree | Priority journal | |
dc.subject.emtree | Schizophrenia | |
dc.subject.scopus | Common Carotid Artery; Fluoro Jade; Gerbillinae | |
dc.subject.wos | Clinical neurology | |
dc.subject.wos | Neurosciences | |
dc.subject.wos | Psychiatry | |
dc.title | The neuroprotective effect of olanzapine | |
dc.type | Article | |
dspace.entity.type | Publication | |
local.contributor.department | Tıp Fakültesi/Nöroloji Ana Bilim Dalı | |
local.indexed.at | PubMed | |
local.indexed.at | Scopus |
Files
License bundle
1 - 1 of 1
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: